Synopsys (SNPS) Stock Forecast & Price Target

Q: What analysts cover Synopsys?

Synopsys has been rated by research analysts at Barclays , Benchmark , BNP Paribas Exane , Deutsche Bank Aktiengesellschaft , HSBC , KeyCorp , Mizuho , Morgan Stanley , Needham & Company LLC , Robert W. Baird , Rosenblatt Securities , Roth Capital , Sanford C. Bernstein , UBS Group , Weiss Ratings , Wells Fargo & Company , and Zacks Research in the past 90 days.

$497.75 -4.92 (-0.98%)

Closing price 10/8/2026 04:00 PM Eastern

Extended Trading

$496.50 -1.25 (-0.25%)

As of 10/8/2026 08:00 PM Eastern

Compare

Synopsys - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 22 Analyst Ratings

Sell
1

Hold
3

Buy
18

Based on 22 Wall Street analysts who have issued ratings for Synopsys in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 22 analysts, 1 has given a sell rating, 3 have given a hold rating, 17 have given a buy rating, and 1 has given a strong buy rating for SNPS.

Consensus Price Target

$584.11
17.35% Upside

According to the 22 analysts' twelve-month price targets for Synopsys, the average price target is $584.11. The highest price target for SNPS is $700.00, while the lowest price target for SNPS is $420.00. The average price target represents a forecasted upside of 17.35% from the current price of $497.75.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for SNPS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Synopsys and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SNPS Analyst Ratings Over Time

Type	Current Forecast 10/9/25 to 10/9/26	1 Month Ago 9/9/25 to 9/9/26	3 Months Ago 7/11/25 to 7/11/26	1 Year Ago 10/9/24 to 10/9/25
Strong Buy	1 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	17 Buy rating(s)	12 Buy rating(s)	10 Buy rating(s)	11 Buy rating(s)
Hold	3 Hold rating(s)	5 Hold rating(s)	5 Hold rating(s)	4 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	4 Sell rating(s)
Consensus Price Target	$584.11	$561.28	$570.06	$575.31
Forecasted Upside	17.35% Upside	42.74% Upside	27.96% Upside	18.77% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Hold

SNPS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

SNPS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Synopsys Stock vs. The Competition

Type	Synopsys	Technology Companies	Broader Market
Consensus Rating Score	2.82	2.23	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	17.35% Upside	643.16% Upside	19.63% Upside
News Sentiment Rating	Positive News See Recent SNPS News	Neutral News	Neutral News

Recent Analyst Forecasts and Stock Ratings

Show

Rating

Upside/Downside

Action

Report Date

0 Results

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
10/2/2026	Zacks Research 4 of 5 stars		Upgrade	Hold ➝ Strong-Buy
10/1/2026	Deutsche Bank Aktiengesellschaft 3 of 5 stars		Reiterated Rating	Buy	$640.00	+33.12%
10/1/2026	KeyCorp 2 of 5 stars	Jason Celino 2 of 5 stars	Boost Target	Overweight	$600.00 ➝ $605.00	+39.10%
10/1/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Quatrochi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$475.00 ➝ $540.00	+24.16%
10/1/2026	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Blair Abernethy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$575.00 ➝ $620.00	+42.55%
9/25/2026	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Buy
9/25/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Frank Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Reduce
9/25/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Outperform
9/25/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Overweight
9/24/2026	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew DeGasperi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Underperform ➝ Neutral	$420.00	+1.68%
Get the Latest News and Ratings for SNPS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Synopsys and its competitors with MarketBeat's FREE daily newsletter.
9/11/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Hold (C) ➝ Hold (C-)
8/27/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$570.00	+24.96%
8/27/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Siti Panigrahi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$600.00 ➝ $550.00	+23.20%
8/27/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jon Vruwink Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Neutral ➝ Outperform	$558.00 ➝ $560.00	+36.59%
8/27/2026	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gary Mobley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$570.00	+39.02%
8/27/2026	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Charles Shi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$580.00	+41.46%
8/19/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lee Simpson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$525.00 ➝ $500.00	+23.98%
6/23/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clarke Jeffries Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$450.00 ➝ $550.00	+18.39%
5/28/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ruben Roy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$550.00 ➝ $600.00	+20.00%
5/28/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kelsey Chia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$600.00 ➝ $610.00	+27.80%
5/28/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vivek Arya Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$515.00 ➝ $600.00	+14.09%
5/27/2026	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$633.00	+18.42%
2/25/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Schneider Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Buy	$600.00	+33.58%
12/11/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Harlan Sur Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$600.00 ➝ $650.00	+37.51%
1/13/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lachlan Brown Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy	$600.00	+21.82%
11/11/2024	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gary Mobley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy	$675.00	+21.35%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 02:44 AM ET.

Should I Buy Synopsys Stock? SNPS Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, October 7, 2026. Please send any questions or comments about these Synopsys pros and cons to contact@marketbeat.com.

Synopsys
Bull Case

Here are some ways that investors could benefit from investing in Synopsys, Inc.:

Synopsys, Inc. has secured new AI chip-design alliances with OpenAI and Amazon, which reinforce its position as a key supplier of software used to design advanced AI semiconductors, with the expanded Amazon relationship described as a potential $1 billion opportunity.
The company's board of directors authorized a $1 billion share-repurchase program on October 5th, which permits the repurchase of up to 1.1% of its shares, a move that generally signals management believes the stock is undervalued and can support earnings per share.
Wall Street analysts maintain a consensus rating of Moderate Buy with an average price target of $584.11, which is significantly higher than the current stock price of $502.67, suggesting potential for further upside.
Synopsys, Inc. reported strong quarterly earnings on August 26th, beating analysts' consensus estimates with $3.91 in earnings per share and $2.48 billion in revenue, while also providing guidance for Q4 2026 EPS of 4.100-4.160.
Recent commentary highlights that AI chips generally require Synopsys software before reaching fabrication, creating a strategic chokepoint that makes the company difficult to route around despite competition.

Synopsys
Bear Case

Investors should be bearish about investing in Synopsys, Inc. for these reasons:

CFO Sudhindra Kankanwadi sold a combined 12,170 shares for roughly $6.0 million across October 5 and 6, reducing his direct holdings by about 40%, which may weigh on investor sentiment after the recent rally.
The stock trades at a demanding valuation with a price-to-earnings ratio of 88.81 and a price-to-earnings-growth ratio of 1.99, raising questions about whether the AI exposure justifies the premium relative to other software stocks.
Market analysis notes that Synopsys shares have declined after several recent earnings beats, suggesting that investor expectations are unusually high and that strong results may already be priced into the stock.
Insider Janet Lee sold 1,144 shares on October 6th at an average price of $502.52, representing a 6.47% decrease in her ownership of the stock, adding to the pattern of recent insider selling.
Concerns remain regarding the company's acquisition debt and slower overall EDA growth, which some analysts argue may offset the long-term growth outlook provided by new AI partnerships.

SNPS Forecast - Frequently Asked Questions

According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Synopsys is $584.11, with a high forecast of $700.00 and a low forecast of $420.00.

22 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Synopsys in the last twelve months. There is currently 1 sell rating, 3 hold ratings, 17 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SNPS shares.

According to analysts, Synopsys's stock has a predicted upside of 17.35% based on their 12-month stock forecasts.

Over the previous 90 days, Synopsys's stock had 8 upgrades and 4 downgrades by analysts.

Synopsys has been rated by research analysts at Barclays, Benchmark, BNP Paribas Exane, Deutsche Bank Aktiengesellschaft, HSBC, KeyCorp, Mizuho, Morgan Stanley, Needham & Company LLC, Robert W. Baird, Rosenblatt Securities, Roth Capital, Sanford C. Bernstein, UBS Group, Weiss Ratings, Wells Fargo & Company, and Zacks Research in the past 90 days.

Analysts like Synopsys more than other "technology" companies. The consensus rating for Synopsys is Moderate Buy while the average consensus rating for "technology" companies is Hold. Learn more on how SNPS compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Synopsys Recommendations

MarketBeat monitors more than a dozen sources for Synopsys analyst ratings, with the most recent rating issued on 10/2/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Synopsys (SNPS) Stock Forecast & Price Target